AMERICAN JOURNAL OF NEURORADIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1007452, encodeId=e268100e452f8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：5.19 submit 5.23 with editor 6.25 under review(中间编辑给我发了一个链接，要所有作者去提交利益冲突声明，然后我没当回事，所以拖了将近一个月。) 7.29 Major Revision 8.7 a revision has been submitted 8.10 accepted 第一次投稿，虽然算是流程比较麻烦的一家杂志，但是只要乖乖按照他说的来，体验还是不错的。第一次返修意见相当友好，提的问题也很诚恳，让人易于接受，只是没想到一次返修就能接受，太惊喜了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e955490938, createdName=ms7000001447925699, createdTime=Thu Aug 12 22:50:35 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553081, encodeId=3da055308128, content=投稿一周后外审under view，外审了大概15天后显示with editor，然后一直持续了十天后又变成under view，这是什么情况？哪位大咖能解释一下？有个师姐比我早投了一周，现在也是一直with editor十多天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Tue Feb 27 23:44:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188236, encodeId=69191188236ed, content=审稿速度:3.0 经验分享：请问大家，现在这个杂志所有作者都要注册AAMC披露后才能送审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/2ad3adf555784a1bbeb4575f83e7cc73/c554a8247d5d4103bda16ec3fd706393.jpg, createdBy=1a1b2501840, createdName=哆啦Q梦, createdTime=Wed Jan 26 10:15:21 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095338, encodeId=65ad20953386b, content=9.13 submitted 9.15 with editor 9.19 under review 9.30 with editor 然后一直是with editor状态到今天已经23天了这是一直找不到审稿人么？我要不要给编辑写信问问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d4a8240407, createdName=ms3000001743955674, createdTime=Sat Oct 22 10:14:54 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208118, encodeId=64b0120811813, content=有大侠知道draft啥意思么，投了一个礼拜都是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69f11653202, createdName=martinyuan1013, createdTime=Sat Apr 02 14:23:22 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=)]

2021-08-12 ms7000001447925699

审稿速度:2.0 | 投稿命中率:50.0
经验分享：5.19 submit
5.23 with editor
6.25 under review(中间编辑给我发了一个链接，要所有作者去提交利益冲突声明，然后我没当回事，所以拖了将近一个月。)
7.29 Major Revision
8.7 a revision has been submitted
8.10 accepted
第一次投稿，虽然算是流程比较麻烦的一家杂志，但是只要乖乖按照他说的来，体验还是不错的。第一次返修意见相当友好，提的问题也很诚恳，让人易于接受，只是没想到一次返修就能接受，太惊喜了。

205 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007452, encodeId=e268100e452f8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：5.19 submit 5.23 with editor 6.25 under review(中间编辑给我发了一个链接，要所有作者去提交利益冲突声明，然后我没当回事，所以拖了将近一个月。) 7.29 Major Revision 8.7 a revision has been submitted 8.10 accepted 第一次投稿，虽然算是流程比较麻烦的一家杂志，但是只要乖乖按照他说的来，体验还是不错的。第一次返修意见相当友好，提的问题也很诚恳，让人易于接受，只是没想到一次返修就能接受，太惊喜了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e955490938, createdName=ms7000001447925699, createdTime=Thu Aug 12 22:50:35 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553081, encodeId=3da055308128, content=投稿一周后外审under view，外审了大概15天后显示with editor，然后一直持续了十天后又变成under view，这是什么情况？哪位大咖能解释一下？有个师姐比我早投了一周，现在也是一直with editor十多天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Tue Feb 27 23:44:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188236, encodeId=69191188236ed, content=审稿速度:3.0 经验分享：请问大家，现在这个杂志所有作者都要注册AAMC披露后才能送审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/2ad3adf555784a1bbeb4575f83e7cc73/c554a8247d5d4103bda16ec3fd706393.jpg, createdBy=1a1b2501840, createdName=哆啦Q梦, createdTime=Wed Jan 26 10:15:21 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095338, encodeId=65ad20953386b, content=9.13 submitted 9.15 with editor 9.19 under review 9.30 with editor 然后一直是with editor状态到今天已经23天了这是一直找不到审稿人么？我要不要给编辑写信问问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d4a8240407, createdName=ms3000001743955674, createdTime=Sat Oct 22 10:14:54 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208118, encodeId=64b0120811813, content=有大侠知道draft啥意思么，投了一个礼拜都是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69f11653202, createdName=martinyuan1013, createdTime=Sat Apr 02 14:23:22 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=)]

2019-09-23 zxt30

我的都with editor 两个月了，是什么情况，可有大侠指导？

270 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007452, encodeId=e268100e452f8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：5.19 submit 5.23 with editor 6.25 under review(中间编辑给我发了一个链接，要所有作者去提交利益冲突声明，然后我没当回事，所以拖了将近一个月。) 7.29 Major Revision 8.7 a revision has been submitted 8.10 accepted 第一次投稿，虽然算是流程比较麻烦的一家杂志，但是只要乖乖按照他说的来，体验还是不错的。第一次返修意见相当友好，提的问题也很诚恳，让人易于接受，只是没想到一次返修就能接受，太惊喜了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e955490938, createdName=ms7000001447925699, createdTime=Thu Aug 12 22:50:35 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553081, encodeId=3da055308128, content=投稿一周后外审under view，外审了大概15天后显示with editor，然后一直持续了十天后又变成under view，这是什么情况？哪位大咖能解释一下？有个师姐比我早投了一周，现在也是一直with editor十多天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Tue Feb 27 23:44:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188236, encodeId=69191188236ed, content=审稿速度:3.0 经验分享：请问大家，现在这个杂志所有作者都要注册AAMC披露后才能送审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/2ad3adf555784a1bbeb4575f83e7cc73/c554a8247d5d4103bda16ec3fd706393.jpg, createdBy=1a1b2501840, createdName=哆啦Q梦, createdTime=Wed Jan 26 10:15:21 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095338, encodeId=65ad20953386b, content=9.13 submitted 9.15 with editor 9.19 under review 9.30 with editor 然后一直是with editor状态到今天已经23天了这是一直找不到审稿人么？我要不要给编辑写信问问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d4a8240407, createdName=ms3000001743955674, createdTime=Sat Oct 22 10:14:54 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208118, encodeId=64b0120811813, content=有大侠知道draft啥意思么，投了一个礼拜都是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69f11653202, createdName=martinyuan1013, createdTime=Sat Apr 02 14:23:22 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=)]

2018-02-27 zhangxin19830818

投稿一周后外审under view，外审了大概15天后显示with editor，然后一直持续了十天后又变成under view，这是什么情况？哪位大咖能解释一下？有个师姐比我早投了一周，现在也是一直with editor十多天了。

457 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007452, encodeId=e268100e452f8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：5.19 submit 5.23 with editor 6.25 under review(中间编辑给我发了一个链接，要所有作者去提交利益冲突声明，然后我没当回事，所以拖了将近一个月。) 7.29 Major Revision 8.7 a revision has been submitted 8.10 accepted 第一次投稿，虽然算是流程比较麻烦的一家杂志，但是只要乖乖按照他说的来，体验还是不错的。第一次返修意见相当友好，提的问题也很诚恳，让人易于接受，只是没想到一次返修就能接受，太惊喜了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e955490938, createdName=ms7000001447925699, createdTime=Thu Aug 12 22:50:35 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553081, encodeId=3da055308128, content=投稿一周后外审under view，外审了大概15天后显示with editor，然后一直持续了十天后又变成under view，这是什么情况？哪位大咖能解释一下？有个师姐比我早投了一周，现在也是一直with editor十多天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Tue Feb 27 23:44:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188236, encodeId=69191188236ed, content=审稿速度:3.0 经验分享：请问大家，现在这个杂志所有作者都要注册AAMC披露后才能送审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/2ad3adf555784a1bbeb4575f83e7cc73/c554a8247d5d4103bda16ec3fd706393.jpg, createdBy=1a1b2501840, createdName=哆啦Q梦, createdTime=Wed Jan 26 10:15:21 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095338, encodeId=65ad20953386b, content=9.13 submitted 9.15 with editor 9.19 under review 9.30 with editor 然后一直是with editor状态到今天已经23天了这是一直找不到审稿人么？我要不要给编辑写信问问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d4a8240407, createdName=ms3000001743955674, createdTime=Sat Oct 22 10:14:54 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208118, encodeId=64b0120811813, content=有大侠知道draft啥意思么，投了一个礼拜都是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69f11653202, createdName=martinyuan1013, createdTime=Sat Apr 02 14:23:22 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=)]

2022-01-26 哆啦Q梦

审稿速度:3.0
经验分享：请问大家，现在这个杂志所有作者都要注册AAMC披露后才能送审吗？

138 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007452, encodeId=e268100e452f8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：5.19 submit 5.23 with editor 6.25 under review(中间编辑给我发了一个链接，要所有作者去提交利益冲突声明，然后我没当回事，所以拖了将近一个月。) 7.29 Major Revision 8.7 a revision has been submitted 8.10 accepted 第一次投稿，虽然算是流程比较麻烦的一家杂志，但是只要乖乖按照他说的来，体验还是不错的。第一次返修意见相当友好，提的问题也很诚恳，让人易于接受，只是没想到一次返修就能接受，太惊喜了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e955490938, createdName=ms7000001447925699, createdTime=Thu Aug 12 22:50:35 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553081, encodeId=3da055308128, content=投稿一周后外审under view，外审了大概15天后显示with editor，然后一直持续了十天后又变成under view，这是什么情况？哪位大咖能解释一下？有个师姐比我早投了一周，现在也是一直with editor十多天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Tue Feb 27 23:44:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188236, encodeId=69191188236ed, content=审稿速度:3.0 经验分享：请问大家，现在这个杂志所有作者都要注册AAMC披露后才能送审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/2ad3adf555784a1bbeb4575f83e7cc73/c554a8247d5d4103bda16ec3fd706393.jpg, createdBy=1a1b2501840, createdName=哆啦Q梦, createdTime=Wed Jan 26 10:15:21 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095338, encodeId=65ad20953386b, content=9.13 submitted 9.15 with editor 9.19 under review 9.30 with editor 然后一直是with editor状态到今天已经23天了这是一直找不到审稿人么？我要不要给编辑写信问问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d4a8240407, createdName=ms3000001743955674, createdTime=Sat Oct 22 10:14:54 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208118, encodeId=64b0120811813, content=有大侠知道draft啥意思么，投了一个礼拜都是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69f11653202, createdName=martinyuan1013, createdTime=Sat Apr 02 14:23:22 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=)]

2022-10-22 ms3000001743955674

9.13 submitted
9.15 with editor
9.19 under review
9.30 with editor
然后一直是with editor状态到今天已经23天了这是一直找不到审稿人么？我要不要给编辑写信问问呢？

62 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007452, encodeId=e268100e452f8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：5.19 submit 5.23 with editor 6.25 under review(中间编辑给我发了一个链接，要所有作者去提交利益冲突声明，然后我没当回事，所以拖了将近一个月。) 7.29 Major Revision 8.7 a revision has been submitted 8.10 accepted 第一次投稿，虽然算是流程比较麻烦的一家杂志，但是只要乖乖按照他说的来，体验还是不错的。第一次返修意见相当友好，提的问题也很诚恳，让人易于接受，只是没想到一次返修就能接受，太惊喜了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e955490938, createdName=ms7000001447925699, createdTime=Thu Aug 12 22:50:35 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553081, encodeId=3da055308128, content=投稿一周后外审under view，外审了大概15天后显示with editor，然后一直持续了十天后又变成under view，这是什么情况？哪位大咖能解释一下？有个师姐比我早投了一周，现在也是一直with editor十多天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Tue Feb 27 23:44:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188236, encodeId=69191188236ed, content=审稿速度:3.0 经验分享：请问大家，现在这个杂志所有作者都要注册AAMC披露后才能送审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/2ad3adf555784a1bbeb4575f83e7cc73/c554a8247d5d4103bda16ec3fd706393.jpg, createdBy=1a1b2501840, createdName=哆啦Q梦, createdTime=Wed Jan 26 10:15:21 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095338, encodeId=65ad20953386b, content=9.13 submitted 9.15 with editor 9.19 under review 9.30 with editor 然后一直是with editor状态到今天已经23天了这是一直找不到审稿人么？我要不要给编辑写信问问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d4a8240407, createdName=ms3000001743955674, createdTime=Sat Oct 22 10:14:54 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208118, encodeId=64b0120811813, content=有大侠知道draft啥意思么，投了一个礼拜都是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69f11653202, createdName=martinyuan1013, createdTime=Sat Apr 02 14:23:22 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=)]

2021-02-24 古天乐

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：胶质瘤MRI影像
经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。

184 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007452, encodeId=e268100e452f8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：5.19 submit 5.23 with editor 6.25 under review(中间编辑给我发了一个链接，要所有作者去提交利益冲突声明，然后我没当回事，所以拖了将近一个月。) 7.29 Major Revision 8.7 a revision has been submitted 8.10 accepted 第一次投稿，虽然算是流程比较麻烦的一家杂志，但是只要乖乖按照他说的来，体验还是不错的。第一次返修意见相当友好，提的问题也很诚恳，让人易于接受，只是没想到一次返修就能接受，太惊喜了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e955490938, createdName=ms7000001447925699, createdTime=Thu Aug 12 22:50:35 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553081, encodeId=3da055308128, content=投稿一周后外审under view，外审了大概15天后显示with editor，然后一直持续了十天后又变成under view，这是什么情况？哪位大咖能解释一下？有个师姐比我早投了一周，现在也是一直with editor十多天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Tue Feb 27 23:44:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188236, encodeId=69191188236ed, content=审稿速度:3.0 经验分享：请问大家，现在这个杂志所有作者都要注册AAMC披露后才能送审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/2ad3adf555784a1bbeb4575f83e7cc73/c554a8247d5d4103bda16ec3fd706393.jpg, createdBy=1a1b2501840, createdName=哆啦Q梦, createdTime=Wed Jan 26 10:15:21 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095338, encodeId=65ad20953386b, content=9.13 submitted 9.15 with editor 9.19 under review 9.30 with editor 然后一直是with editor状态到今天已经23天了这是一直找不到审稿人么？我要不要给编辑写信问问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d4a8240407, createdName=ms3000001743955674, createdTime=Sat Oct 22 10:14:54 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208118, encodeId=64b0120811813, content=有大侠知道draft啥意思么，投了一个礼拜都是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69f11653202, createdName=martinyuan1013, createdTime=Sat Apr 02 14:23:22 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=)]

2022-04-02 martinyuan1013

有大侠知道draft啥意思么，投了一个礼拜都是这个状态

149 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007452, encodeId=e268100e452f8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：5.19 submit 5.23 with editor 6.25 under review(中间编辑给我发了一个链接，要所有作者去提交利益冲突声明，然后我没当回事，所以拖了将近一个月。) 7.29 Major Revision 8.7 a revision has been submitted 8.10 accepted 第一次投稿，虽然算是流程比较麻烦的一家杂志，但是只要乖乖按照他说的来，体验还是不错的。第一次返修意见相当友好，提的问题也很诚恳，让人易于接受，只是没想到一次返修就能接受，太惊喜了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e955490938, createdName=ms7000001447925699, createdTime=Thu Aug 12 22:50:35 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553081, encodeId=3da055308128, content=投稿一周后外审under view，外审了大概15天后显示with editor，然后一直持续了十天后又变成under view，这是什么情况？哪位大咖能解释一下？有个师姐比我早投了一周，现在也是一直with editor十多天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Tue Feb 27 23:44:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188236, encodeId=69191188236ed, content=审稿速度:3.0 经验分享：请问大家，现在这个杂志所有作者都要注册AAMC披露后才能送审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/2ad3adf555784a1bbeb4575f83e7cc73/c554a8247d5d4103bda16ec3fd706393.jpg, createdBy=1a1b2501840, createdName=哆啦Q梦, createdTime=Wed Jan 26 10:15:21 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095338, encodeId=65ad20953386b, content=9.13 submitted 9.15 with editor 9.19 under review 9.30 with editor 然后一直是with editor状态到今天已经23天了这是一直找不到审稿人么？我要不要给编辑写信问问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d4a8240407, createdName=ms3000001743955674, createdTime=Sat Oct 22 10:14:54 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208118, encodeId=64b0120811813, content=有大侠知道draft啥意思么，投了一个礼拜都是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69f11653202, createdName=martinyuan1013, createdTime=Sat Apr 02 14:23:22 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

选刊时需结合分区进行吗？

133 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007452, encodeId=e268100e452f8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：5.19 submit 5.23 with editor 6.25 under review(中间编辑给我发了一个链接，要所有作者去提交利益冲突声明，然后我没当回事，所以拖了将近一个月。) 7.29 Major Revision 8.7 a revision has been submitted 8.10 accepted 第一次投稿，虽然算是流程比较麻烦的一家杂志，但是只要乖乖按照他说的来，体验还是不错的。第一次返修意见相当友好，提的问题也很诚恳，让人易于接受，只是没想到一次返修就能接受，太惊喜了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e955490938, createdName=ms7000001447925699, createdTime=Thu Aug 12 22:50:35 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553081, encodeId=3da055308128, content=投稿一周后外审under view，外审了大概15天后显示with editor，然后一直持续了十天后又变成under view，这是什么情况？哪位大咖能解释一下？有个师姐比我早投了一周，现在也是一直with editor十多天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Tue Feb 27 23:44:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188236, encodeId=69191188236ed, content=审稿速度:3.0 经验分享：请问大家，现在这个杂志所有作者都要注册AAMC披露后才能送审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/2ad3adf555784a1bbeb4575f83e7cc73/c554a8247d5d4103bda16ec3fd706393.jpg, createdBy=1a1b2501840, createdName=哆啦Q梦, createdTime=Wed Jan 26 10:15:21 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095338, encodeId=65ad20953386b, content=9.13 submitted 9.15 with editor 9.19 under review 9.30 with editor 然后一直是with editor状态到今天已经23天了这是一直找不到审稿人么？我要不要给编辑写信问问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d4a8240407, createdName=ms3000001743955674, createdTime=Sat Oct 22 10:14:54 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208118, encodeId=64b0120811813, content=有大侠知道draft啥意思么，投了一个礼拜都是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69f11653202, createdName=martinyuan1013, createdTime=Sat Apr 02 14:23:22 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=)]

2021-12-28 rayms

期刊分类很多，如何选择合适的期刊？

139 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1007452, encodeId=e268100e452f8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：5.19 submit 5.23 with editor 6.25 under review(中间编辑给我发了一个链接，要所有作者去提交利益冲突声明，然后我没当回事，所以拖了将近一个月。) 7.29 Major Revision 8.7 a revision has been submitted 8.10 accepted 第一次投稿，虽然算是流程比较麻烦的一家杂志，但是只要乖乖按照他说的来，体验还是不错的。第一次返修意见相当友好，提的问题也很诚恳，让人易于接受，只是没想到一次返修就能接受，太惊喜了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e955490938, createdName=ms7000001447925699, createdTime=Thu Aug 12 22:50:35 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576800, encodeId=bae25e680067, content=我的都with editor 两个月了，是什么情况，可有大侠指导？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/03/d88dbb51b15f357a190ae322d1c67080.jpg, createdBy=4d7f1612580, createdName=zxt30, createdTime=Mon Sep 23 21:24:00 CST 2019, time=2019-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553081, encodeId=3da055308128, content=投稿一周后外审under view，外审了大概15天后显示with editor，然后一直持续了十天后又变成under view，这是什么情况？哪位大咖能解释一下？有个师姐比我早投了一周，现在也是一直with editor十多天了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Tue Feb 27 23:44:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188236, encodeId=69191188236ed, content=审稿速度:3.0 经验分享：请问大家，现在这个杂志所有作者都要注册AAMC披露后才能送审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/2ad3adf555784a1bbeb4575f83e7cc73/c554a8247d5d4103bda16ec3fd706393.jpg, createdBy=1a1b2501840, createdName=哆啦Q梦, createdTime=Wed Jan 26 10:15:21 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095338, encodeId=65ad20953386b, content=9.13 submitted 9.15 with editor 9.19 under review 9.30 with editor 然后一直是with editor状态到今天已经23天了这是一直找不到审稿人么？我要不要给编辑写信问问呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d4a8240407, createdName=ms3000001743955674, createdTime=Sat Oct 22 10:14:54 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926851, encodeId=961d92685113, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：胶质瘤MRI影像 经验分享：期刊还是比较友好型的，审稿人提了挺多问题，想拒稿。但审稿人还是给我一个返修的机会，结果补充了很多佐证材料后，顺利接收，编辑还是比较nice.所以在返修的时候，特别要认认真真回答。最好让别人帮你改改Response letter。能满足尽量满足审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Wed Feb 24 13:54:36 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208118, encodeId=64b0120811813, content=有大侠知道draft啥意思么，投了一个礼拜都是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69f11653202, createdName=martinyuan1013, createdTime=Sat Apr 02 14:23:22 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086471, encodeId=298b10864e13b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086472, encodeId=2ea710864e28a, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584333, encodeId=fe635843331e, content=这个杂志需要版面费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Thu Feb 06 00:00:00 CST 2020, time=2020-02-06, status=1, ipAttribution=)]

2020-02-06 Atropine1470

这个杂志需要版面费么？

230 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务